Studies on rotavirus vaccine shedding and its potential transmission within households including immunocompromised individuals are needed to better define the potential risks and benefits of vaccination. We examined fecal shedding of pentavalent rotavirus vaccine (RV5) for 9 days following the first dose of vaccine in infants between 6 and 12 weeks of age. Rotavirus antigen was detected by enzyme immunoassay (EIA), and vaccine-type rotavirus was identified by nucleotide sequencing based on genetic relatedness to the RV5 VP6 gene. Stool from 22 (21.4%) of 103 children contained rotavirus antigen-positive specimens on ≥1 post-vaccination days. Rotavirus antigen was detected as early as post-vaccination day 3 and as late as day 9, with peak numbers of shedding on post-vaccination days 6 through 8. Vaccine-type rotavirus was detected in all 50 antigen-positive specimens and 8 of 8 antigen-negative specimens. Nine (75%) of 12 EIA-positive and 1 EIA-negative samples tested culture-positive for vaccine-type rotavirus. Fecal shedding of rotavirus vaccine virus after the first dose of RV5 occurred over a wide range of post-vaccination days not previously studied. These findings will help better define the potential for horizontal transmission of vaccine virus among immunocompromised household contacts of vaccinated infants for future studies.

The aim of this paper was to determine the frequency of Canalis Sinuosus (CS) and its anatomic variations. A total of 236 cone beam computed tomography (CBCT) images were studied. Characteristics of the canal such as its form, pathway and diameter were analyzed. The CS was clearly visualized in 100 % of the images with variations in the canal observed in up to 46 % of the cases. In 79 % of the cases the variation was found to be bilateral. The most common variation was an increase in the diameter (> 1mm) of the CS. Considering that the anterior region of the middle third of the face is a common place for clinical interventions, this study supports the need to perform a thorough evaluation of the maxillary region prior to clinical interventions in order to prevent complications such as direct or indirect injury to the anterior superior alveolar neurovascular bundle contained within the CS.

Introduction: The styloid process is a cone-shaped process of the temporal bone with a normal length of 20 to 30 mm. It is considered "elongated" when its length is greater than 30mm. A temporal styloid process with a length of 25mm or more may cause Eagle's syndrome, a condition characterized by multiple clinical symptoms that can be explained by the anatomical relationships of the styloid process. The length of the styloid process depends on demographic variables such as race and geographical distribution; therefore normal patterns may vary among different populations. Due to its non-specific clinical manifestations, it would be relevant to know its prevalence in a specific population. The aim of this study was to determine the frequency of styloid process elongation in a sample of the Colombian population. Material and Methods: The study was a cross-sectional, observational descriptive study. The length of 46 styloid processes from their origin to their vertex was determined in 46 hemifacial dissections. The corresponding right or left side of the head of the styloid process was also recorded. Results: The obtained average length of styloid processes was 35.1 ± 13.2 mm. 23 styloid processes (50%) measured over 30 mm, and 38 processes (82.6%) measured 25 mm or more. Conclusion: Since previous reports have shown that the onset of symptoms is variable and sometimes independent of the length of the styloid process, we suggest that the angulation of the styloid process is a clinical consideration as important as the length of the styloid process.